GHK-Cu for hair growth: peptide hype vs. actual evidence

What's this video probably claiming?

A TikTok account literally named "gears_peptides_supplys" posting under #hairgrowth and #peptide is almost certainly pitching GHK-Cu (copper peptide) as a hair loss solution, probably alongside claims about stimulating follicle regeneration, increasing hair density, and reversing thinning. These accounts typically frame peptides as the thing your dermatologist won't tell you about, often with before/after framing or references to "biohacking" your way out of androgenic alopecia. There's also a reasonable chance the video touches on BPC-157 or TB-500 in the context of healing and growth, since this creator's catalog appears to cover the full peptide menu. The sales angle is baked into the username itself. That context matters when you're evaluating how the evidence gets presented.

What does the science actually show?

GHK-Cu has genuinely interesting preliminary data, and that's exactly why it gets oversold. Pickart et al. (2015, Journal of Aging Science) documented GHK-Cu's role in activating genes related to tissue repair and growth factor signaling. More directly relevant to hair, Kang et al. (2014, Archives of Dermatological Research) found that GHK-Cu stimulated hair follicle proliferation in vitro and increased hair follicle size in mice at concentrations of 1-10 nM. A small human study by Uno and Kurata (1993, Journal of Investigative Dermatology) showed topical copper peptide application increased follicle size by approximately 42% versus placebo in 48 subjects over 12 weeks. That sounds impressive until you note the sample size, the fact that no study has replicated those numbers in a rigorous RCT, and that none of this data compares GHK-Cu to minoxidil or finasteride, the actual evidence-based standards of care for androgenic alopecia.

Where does the social media noise diverge from clinical reality?

The gap between "has biological plausibility" and "works reliably in humans at doses you can buy online" is where TikTok peptide content consistently falls apart. GHK-Cu is not FDA-approved for hair loss. Compounded injectable or topical versions have zero standardized dosing protocols validated in large human trials. The biohacking framing implies a level of self-directed optimization that ignores real variables: the copper concentration in formulations sold by gray-market suppliers varies wildly, absorption through intact scalp skin is poorly characterized, and systemic copper toxicity, while rare, is a documented risk with unregulated use. Social media also conflates topical GHK-Cu skincare products (which have some safety data) with injectable peptide protocols, as if they're the same intervention. They are not remotely the same. Accounts selling peptide supplies have an obvious financial interest in making this distinction disappear.

What should you actually know?

If you're losing hair, the treatments with the strongest evidence remain minoxidil (FDA-approved topical, roughly 40-60% of users see stabilization or regrowth per Olsen et al., 2002, Journal of the American Academy of Dermatology) and finasteride for men (5-alpha reductase inhibitor, approximately 83% of men showed no further loss at 2 years per Kaufman et al., 1998, Journal of the American Academy of Dermatology). GHK-Cu might eventually earn a meaningful place in evidence-based hair loss treatment. Right now it has intriguing preclinical data and a handful of small human studies. What it does not have is the clinical trial infrastructure to support confident dosing recommendations, and it absolutely does not have the safety profile characterization that comes from large-scale regulated use. Buying peptides from a TikTok account named after supplying gears and peptides is a different risk calculus than a supervised clinical protocol.